Cargando…

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction

Patients with neurogenic lower urinary tract dysfunction (NLUTD) experience urinary incontinence with or without difficult urination, which might promote recurrent urinary tract infection (UTI) and exacerbate upper urinary tract function. Nonetheless, appropriate bladder management has been shown to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yuan-Hong, Chen, Sheng-Fu, Kuo, Hann-Chorng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Continence Society 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788334/ https://www.ncbi.nlm.nih.gov/pubmed/33401351 http://dx.doi.org/10.5213/inj.2040354.177

Ejemplares similares

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
por: Kuo, Hann-Chorng
Publicado: (2020)

Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action
por: Jhang, Jia-Fong, et al.
Publicado: (2016)

Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women
por: Jiang, Yuan-Hong, et al.
Publicado: (2021)

Clinical Application of Botulinum Neurotoxin in Lower-Urinary-Tract Diseases and Dysfunctions: Where Are We Now and What More Can We Do?
por: Kuo, Hann-Chorng
Publicado: (2022)

Role of videourodynamic study in precision diagnosis and treatment for lower urinary tract dysfunction
por: Jiang, Yuan-Hong, et al.
Publicado: (2019)

Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction
por: Jhang, Jia-Fong, et al.
Publicado: (2018)

Intravesical botulinum toxin for lower urinary tract dysfunction
por: John Drake, Marcus
Publicado: (2010)

Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment
por: Jiang, Yuan-Hong, et al.
Publicado: (2018)

Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction
por: Kuo, Hann-Chorng
Publicado: (2016)

New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction
por: Miyazato, Minoru, et al.
Publicado: (2017)

Long-Term Follow-Up of Lower Urinary Tract Outcome in Children with Dysfunctional Voiding
por: Peng, Chung-Hsin, et al.
Publicado: (2022)

A Precision Urodynamic Diagnosis is Essential for Successful Treatment of Lower Urinary Tract Dysfunction
por: Kuo, Hann-Chorng
Publicado: (2022)

Current Surgical Treatment for Neurogenic Lower Urinary Tract Dysfunction in Patients with Chronic Spinal Cord Injury
por: Fan, Yu-Hua, et al.
Publicado: (2023)

Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
por: Chiang, Bing-Juin, et al.
Publicado: (2019)

Botulinum Toxin Use in the Lower Urinary Tract
por: Morrisroe, Shelby N., et al.
Publicado: (2007)

Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions
por: Yu, Wan-Ru, et al.
Publicado: (2023)

Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most?
por: Chen, Sheng-Fu, et al.
Publicado: (2023)

Botulinum Toxin Brings a Light to the Shadow of Functional Urology
por: Kuo, Hann-Chorng
Publicado: (2023)

Recent research on the role of urodynamic study in the diagnosis and treatment of male lower urinary tract symptoms and urinary incontinence
por: Jiang, Yuan-Hong, et al.
Publicado: (2017)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
por: Chen, Sheng-Fu, et al.
Publicado: (2016)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
por: Chen, Jing-Liang, et al.
Publicado: (2020)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
por: Chen, Sheng-Fu, et al.
Publicado: (2020)

The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction
por: Kao, Yao-Lin, et al.
Publicado: (2019)

Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions
por: Lee, Yu-Khun, et al.
Publicado: (2019)

Urothelial Dysfunction and Increased Suburothelial Inflammation of Urinary Bladder Are Involved in Patients with Upper Urinary Tract Urolithiasis – Clinical and Immunohistochemistry Study
por: Jiang, Yuan-Hong, et al.
Publicado: (2014)

Editorial Comment: Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2021)

Novel Applications of Non-Invasive Intravesical Botulinum Toxin a Delivery in the Treatment of Functional Bladder Disorders
por: Jhang, Jia-Fong, et al.
Publicado: (2021)

International Prostatic Symptom Score — Voiding/Storage Subscore Ratio in Association with Total Prostatic Volume and Maximum Flow Rate Is Diagnostic of Bladder Outlet-Related Lower Urinary Tract Dysfunction in Men with Lower Urinary Tract Symptoms
por: Jiang, Yuan-Hong, et al.
Publicado: (2013)

Therapeutic Effect of Botulinum Toxin A on Sensory Bladder Disorders—From Bench to Bedside
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

Chinese botulinum toxin A for the treatment of lower urinary tract dysfunction: It works just as well
por: Zhang, Fan, et al.
Publicado: (2022)

Correction: International Prostatic Symptom Score — Voiding/Storage Subscore Ratio in Association with Total Prostatic Volume and Maximum Flow Rate Is Diagnostic of Bladder Outlet-Related Lower Urinary Tract Dysfunction in Men with Lower Urinary Tract Symptoms
por: Jiang, Yuan-Hong, et al.
Publicado: (2013)

Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
por: Hung, Fan-Ching, et al.
Publicado: (2022)

Changes of lower urinary tract function after robot-assisted radical prostatectomy: An urodynamic follow-up within 1 year
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients—When Intravesical Botox Injection or Urethral Botox Injection Are Indicated
por: Chen, Po-Cheng, et al.
Publicado: (2023)

Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts
por: Lee, Cheng-Ling, et al.
Publicado: (2017)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
por: Liao, Chun-Hou, et al.
Publicado: (2015)

Botulinum Toxin A Injection for Autonomic Dysreflexia—Detrusor Injection or Urethral Sphincter Injection?
por: Chow, Po-Ming, et al.
Publicado: (2023)

Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children
por: Fan, Yu-Hua, et al.
Publicado: (2023)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_00burtss9atq8dpks32kv2f9i6